Your browser doesn't support javascript.
loading
Differential Iron Requirements for Osteoblast and Adipocyte Differentiation.
Edwards, Daniel F; Miller, Christopher J; Quintana-Martinez, Arelis; Wright, Christian S; Prideaux, Matthew; Atkins, Gerald J; Thompson, William R; Clinkenbeard, Erica L.
Afiliação
  • Edwards DF; Department of Medical and Molecular Genetics School of Medicine, Indiana University Indianapolis IN USA.
  • Miller CJ; Department of Medical and Molecular Genetics School of Medicine, Indiana University Indianapolis IN USA.
  • Quintana-Martinez A; Department of Medical and Molecular Genetics School of Medicine, Indiana University Indianapolis IN USA.
  • Wright CS; Department of Physical Therapy School of Health & Human Sciences, Indiana University Indianapolis IN USA.
  • Prideaux M; Indiana Center for Musculoskeletal Health Indiana University Indianapolis IN USA.
  • Atkins GJ; Centre for Orthopaedic & Trauma Research University of Adelaide Adelaide South Australia Australia.
  • Thompson WR; Department of Physical Therapy School of Health & Human Sciences, Indiana University Indianapolis IN USA.
  • Clinkenbeard EL; Department of Medical and Molecular Genetics School of Medicine, Indiana University Indianapolis IN USA.
JBMR Plus ; 5(9): e10529, 2021 Sep.
Article em En | MEDLINE | ID: mdl-34532614
ABSTRACT
Bone marrow mesenchymal progenitor cells are precursors for various cell types including osteoblasts, adipocytes, and chondrocytes. The external environment and signals act to direct the pathway of differentiation. Importantly, situations such as aging and chronic kidney disease display alterations in the balance of osteoblast and adipocyte differentiation, adversely affecting bone integrity. Iron deficiency, which can often occur during aging and chronic kidney disease, is associated with reduced bone density. The purpose of this study was to assess the effects of iron deficiency on the capacity of progenitor cell differentiation pathways. Mouse and human progenitor cells, differentiated under standard osteoblast and adipocyte protocols in the presence of the iron chelator deferoxamine (DFO), were used. Under osteogenic conditions, 5µM DFO significantly impaired expression of critical osteoblast genes, including osteocalcin, type 1 collagen, and dentin matrix protein 1. This led to a reduction in alkaline phosphatase activity and impaired mineralization. Despite prolonged exposure to chronic iron deficiency, cells retained viability as well as normal hypoxic responses with significant increases in transferrin receptor and protein accumulation of hypoxia inducible factor 1α. Similar concentrations of DFO were used when cells were maintained in adipogenic conditions. In contrast to osteoblast differentiation, DFO modestly suppressed adipocyte gene expression of peroxisome-proliferating activated receptor gamma, lipoprotein lipase, and adiponectin at earlier time points with normalization at later stages. Lipid accumulation was also similar in all conditions. These data suggest the critical importance of iron in osteoblast differentiation, and as long as the external stimuli are present, iron deficiency does not impede adipogenesis. © 2021 The Authors. JBMR Plus published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: JBMR Plus Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: JBMR Plus Ano de publicação: 2021 Tipo de documento: Article